[REVISION HISTORY]

STAREE trial and evolving cholesterol treatments

8 recorded revisions of this situation.

What changed

2026-09-30 14:52 UTC → 2026-10-05 03:04 UTC · added ~~removed~~

The STAREE trial, a large-scale clinical study involving nearly 10,000 participants from Australian general practices, has demonstrated that daily atorvastatin significantly reduces the risk of major cardiovascular events in healthy adults aged 70 and older. Findings published in the New England Journal of Medicine indicate a 30 per cent reduction in the risk of cardiovascular death, nonfatal myocardial infarction, stroke, and coronary revascularization among participants with no prior history of cardiovascular disease, diabetes, or dementia. While the medication successfully lowered cardiovascular risks, researchers noted that it did not significantly improve mortality, dementia, or disability-free survival. Newer details from the study, presented at the European Society of Cardiology congress, specify that the research led by Professor Sophia Zoungas of Monash University involved 9,971 participants with a median follow-up of 5.9 years. While the 30 per cent reduction in serious cardiovascular events was significant, the study noted that participants receiving 40 mg of atorvastatin experienced higher rates of muscle, liver, and diabetes-related side effects compared to the control group. However, the overall rate of serious adverse events remained equal between both groups at 2.7 per cent. Recent research has further nuanced the approach to preventative care for the elderly. A study published in The Lancet Healthy Longevity suggests that adults aged 75 and older may safely discontinue primary prevention statin therapy if they have no history of heart attack or stroke. Following approximately 1,200 adults with a mean age of 80, researchers found that those who stopped the medication showed no significant increase in mortality over three years compared to those who continued, though discontinuation did not improve quality of life, physical function, or mental well-being. Additionally, research ~~led by Brown University and~~ published in the Annals of Internal Medicine indicates that the herpes-zoster vaccine may reduce the risk of dementia in older adults. Newer investigations have sought to clarify the biological mechanisms and side-effect profiles of statins. Research published in Nature Communications suggests that atorvastatin may interfere with the RyR1 protein, ~~causing a calcium leak that stresses muscle tissue and~~ potentially ~~explains~~ explaining reported muscle pain. Conversely, a large-scale analysis of 19 clinical trials published in The Lancet involving over 123,000 individuals found no significant increased risk for depression, sleep problems, fatigue, or headaches when comparing statins to a placebo.

Versions

Select a version to see what changed compared to the one before it.